AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | Drug Overview & Clinical Reference
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Clinical safety rating: safe
Weak CYP3A4 inhibitors may increase levels but no dosage adjustment is typically needed Monitor for hypotension and peripheral edema dose-related side effects.
How it works
Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.
Dosing & administration
Tablet 5 mg - Oral
Dosage form
TABLET
Renal impairment
Consult protocols for adjustment.
Liver impairment
Consult protocols for adjustment.
Use during pregnancy
1st trimester
Consult provider
2nd trimester
Consult provider
3rd trimester
Consult provider
Clinical note
Weak CYP3A4 inhibitors may increase levels but no dosage adjustment is typically needed Monitor for hypotension and peripheral edema dose-related side effects.
